TG Therapeutics Financial Overview
TG Therapeutics's market cap is currently $4.94B. The company's EPS TTM is $2.43; its P/E ratio is 10.77; TG Therapeutics is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.
